- Home
- LTC vs TXG Comparison
LTC vs TXG Comparison
Compare LTC & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTC
- TXG
- Stock Information
- Founded
- LTC 1992
- TXG 2012
- Country
- LTC United States
- TXG United States
- Employees
- LTC N/A
- TXG N/A
- Industry
- LTC Real Estate Investment Trusts
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- LTC Real Estate
- TXG Industrials
- Exchange
- LTC Nasdaq
- TXG Nasdaq
- Market Cap
- LTC 1.7B
- TXG 1.6B
- IPO Year
- LTC 1992
- TXG 2019
- Fundamental
- Price
- LTC $34.83
- TXG $11.76
- Analyst Decision
- LTC Hold
- TXG Buy
- Analyst Count
- LTC 5
- TXG 12
- Target Price
- LTC $38.80
- TXG $13.54
- AVG Volume (30 Days)
- LTC 401.5K
- TXG 2.7M
- Earning Date
- LTC 10-27-2025
- TXG 10-28-2025
- Dividend Yield
- LTC 6.53%
- TXG N/A
- EPS Growth
- LTC N/A
- TXG N/A
- EPS
- LTC 1.81
- TXG N/A
- Revenue
- LTC $213,197,000.00
- TXG $644,466,000.00
- Revenue This Year
- LTC N/A
- TXG $2.15
- Revenue Next Year
- LTC N/A
- TXG N/A
- P/E Ratio
- LTC $19.33
- TXG N/A
- Revenue Growth
- LTC 8.74
- TXG 2.02
- 52 Week Low
- LTC $31.70
- TXG $6.78
- 52 Week High
- LTC $39.89
- TXG $20.92
- Technical
- Relative Strength Index (RSI)
- LTC 37.01
- TXG 41.80
- Support Level
- LTC $36.21
- TXG $11.22
- Resistance Level
- LTC $37.25
- TXG $13.22
- Average True Range (ATR)
- LTC 0.61
- TXG 0.57
- MACD
- LTC -0.13
- TXG 0.00
- Stochastic Oscillator
- LTC 11.73
- TXG 27.18
About LTC LTC Properties Inc.
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in seniors housing and healthcare facilities through mortgage loans, property lease transactions, and other investments. Its real estate investments includes different types of properties such as Independent living communities, Assisted living communities, Memory care communities, Skilled nursing centers and other types of properties.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).